Kaposiform Hemangioendothelioma

Explore clinical trials studying Kaposiform Hemangioendothelioma. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Kaposiform Hemangioendothelioma trial results

Recruiting

The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma

NCT05351216

Conditions: Kaposiform Hemangioendothelioma
Locations: Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Identification of Biomarkers for Patients with Vascular Anomalies

NCT03001180

Conditions: Angiomatosis, Bone Diseases, Bone Diseases, Developmental, +18 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Not Yet Recruiting

Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma

NCT07131644

Conditions: Kaposiform Hemangioendothelioma
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Completed

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.

NCT04775173

Conditions: Kaposiform Hemangioendothelioma
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Completed

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

NCT04448873

Conditions: Blood Platelet Disorders, Cytopenia, Hemangioma, +8 more
Locations: Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

NCT04077515

Conditions: Blood Platelet Disorders, Cytopenia, Hemangioma, +8 more
Locations: Children's Hospital of Fudan University Shanghai, China

View Trial Details

Completed

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

NCT03188068

Conditions: Blood Platelet Disorders, Cytopenia, Hemangioma, +9 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Kaposiform Hemangioendothelioma

Kaposiform Hemangioendothelioma trial results

The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma

Identification of Biomarkers for Patients with Vascular Anomalies

Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

Related conditions